1495 related articles for article (PubMed ID: 17118313)
81. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
[TBL] [Abstract][Full Text] [Related]
82. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
[TBL] [Abstract][Full Text] [Related]
83. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract][Full Text] [Related]
84. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
[TBL] [Abstract][Full Text] [Related]
85. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
Lei X; Shan JL; Tang C; Zhao KW
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
[TBL] [Abstract][Full Text] [Related]
86. HDR brachytherapy for the reirradiation of cervical and vaginal cancer: analysis of efficacy and dosage delivered to organs at risk.
Zolciak-Siwinska A; Bijok M; Jonska-Gmyrek J; Kawczynska M; Kepka L; Bujko K; Michalski W
Gynecol Oncol; 2014 Jan; 132(1):93-7. PubMed ID: 24161366
[TBL] [Abstract][Full Text] [Related]
87. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
[TBL] [Abstract][Full Text] [Related]
88. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
89. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
[TBL] [Abstract][Full Text] [Related]
90. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading.
Brooks S; Bownes P; Lowe G; Bryant L; Hoskin PJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):934-9. PubMed ID: 16199322
[TBL] [Abstract][Full Text] [Related]
91. Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy.
Hauswald H; Stoiber E; Rochet N; Lindel K; Grehn C; Becker HD; Debus J; Harms W
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):373-7. PubMed ID: 19836162
[TBL] [Abstract][Full Text] [Related]
92. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
93. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
[TBL] [Abstract][Full Text] [Related]
94. Fractionation in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):907-14. PubMed ID: 8751399
[TBL] [Abstract][Full Text] [Related]
95. [Brachytherapy boost irradiation in the treatment of high risk, localised prostate cancer. Initial national experience in Hungary].
Agoston P; Major T; Somogyi A; Szûcs M; Danczig A; Lövey J; Polgár C; Fodor J; Németh G; Kásler M
Magy Onkol; 2004; 48(1):81-8. PubMed ID: 15105901
[TBL] [Abstract][Full Text] [Related]
96. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
[TBL] [Abstract][Full Text] [Related]
97. Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer.
Chen SW; Liang JA; Yang SN; Hung YC; Yeh LS; Shiau AC; Lin FJ
Gynecol Oncol; 2004 Oct; 95(1):208-14. PubMed ID: 15385134
[TBL] [Abstract][Full Text] [Related]
98. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
[TBL] [Abstract][Full Text] [Related]
99. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
[TBL] [Abstract][Full Text] [Related]
100. High-dose-rate brachytherapy in primary stage I and II vaginal cancer.
Nanavati PJ; Fanning J; Hilgers RD; Hallstrom J; Crawford D
Gynecol Oncol; 1993 Oct; 51(1):67-71. PubMed ID: 8244177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
